Kamonlatth Rodponthukwaji, PhD, a researcher from the Research Department at Siriraj Hospital, Faculty of Medicine, Mahidol University, attended and presented a poster at the 8th International Conference on Multifunctional, Hybrid and Nanomaterials held in Montpellier, France, from March 3rd to 6th, 2025. Dr. Rodponthukwaji presented a poster titled “Development of a targeted dual-ligand liposomal system to improve therapeutic efficacy against mutant glioblastoma”.
Dr. Rodponthukwaji’s participation will benefit Siriraj Hospital by fostering research collaborations, increasing academic recognition, and advancing nanomedicine applications. Through engagement with leading experts and institutions, the hospital can establish new partnerships for joint research, secure funding opportunities, and facilitate technology transfer. The insights gained from the conference can drive innovation in diagnostics, drug delivery, and biomaterials, ultimately contributing to improved patient care.
Punnida Nonsuwan, PhD, a researcher from the Research Department at Siriraj Hospital, Faculty of Medicine, Mahidol University, attended and presented a poster at the 8th International Conference on Multifunctional, Hybrid and Nanomaterials held in Montpellier, France, from March 3rd to 6th, 2025.
Dr. Nonsuwan’s participation provided valuable insights into the latest advancements in nanomaterials and their medical applications for Siriraj. Engaging with cutting-edge research, Siriraj is poised to enhance its own research initiatives, particularly in nanomedicine, targeted drug delivery, and diagnostic technologies. Collaboration opportunities with leading researchers and institutions could catalyze new clinical trials, innovative research projects, and the development of advanced therapies. This exchange of knowledge aims to bolster Siriraj’s commitment to advancing medical research and improving patient care through emerging technologies.
Mr. Thanawat Suwatthanarak. PhD, a researcher from Siriraj Cancer Center, attended the international conference ESMO Targeted Anticancer Therapies Congress 2025 held between March 3rd – 5th, 2025, in Paris, France, to present a research poster titled “Tetraspanins CD37 and CD53: Immune Modulators in Stage IV Colorectal Cancer—A Single-Cell Spatial Transcriptomic Study for Targeted Therapeutic Insights”.
The ESMO Targeted Anticancer Therapies (TAT) Congress 2025 focuses on early-phase clinical trials and new drug development in oncology, often referred to as the “home of phase I in oncology.”
From February 26th – March 2nd, 2025, Assoc. Prof. Rathachai Kaewlai, MD, of the Division of Diagnostic Radiology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, attended The European Congress of Radiology 2025 in Vienna, Austria, to deliver a special lecture on the topic “Top Five US Diagnoses in the Emergency Department.”
The European Society of Radiology (ESR) is an apolitical, non-profit organization dedicated to strengthening and unifying European radiology to improve the diagnosis, treatment, and prevention of diseases while offering their members opportunities to learn, connect, and thrive.
Assoc. Prof. Anirut Pattaragarn, MD, Head of the Division of Nephrology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, participated in the 20th Congress of the International Pediatric Nephrology Association held in Cape Town, South Africa, from February 19th – 23rd, 2025. He presented an e-poster titled “Clinicopathological Characteristics and Kidney Outcomes in Childhood Lupus Nephritis with Kidney Thrombotic Microangiopathy”.
Assoc. Prof. Pattaragarn’s attendance not only enhanced his knowledge and broadened his perspectives, benefiting his colleagues, fellows, and residents in training at Siriraj, but also contributed to advancing research and improving patient care.
The IPNA is a global, nonprofit charitable organization that believes all children deserve to be healthy and receive optimal treatment and care for kidney disease regardless of their economic level or political choice.
